NV
Novavax
NVAX·NASDAQGaithersburg MDFounded 19871,700 employees
Mid CapbiotechPublicInfectious Disease
Platform: Nanopart Vax
Market Cap
$2B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (NVAX)
Loading NVAX stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Motanesiran | NVA-6985 | Phase 2/3 | 1 | PLK4 | HSNarcolepsy | ||
| NVA-5991 | NVA-5991 | Phase 1 | 2 | ALK | Ewing Sarcoma |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (1)